Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On Friday 29 September hundreds of researchers took to Oxford’s streets, gardens, museums and libraries to take part in the Curiosity Carnival, an event which celebrated and debated the way that research affects all our lives. Part of European Researcher’s Night, it was one of hundreds of events taking place across Europe.

Over 9000 people took part in activities led by researchers from across all Divisions, as well as from partner organisations Oxford Brookes University and MRC Harwell. 

"The Curiosity Carnival is another first for Oxford. We are delighted to have this opportunity to showcase our world leading research, and engage with the community on projects that will shape all our futures." - Professor Louise Richardson, Vice Chancellor of the University of Oxford

Medical Sciences Division researchers were out in force to bring their research to the public. Musical numbers attracted lots of attention, with the Oxford Belles helping psychologist Robin Dunbar explore singing and social cohesion, while the Sleep and Circadian Neuroscience Institute organised a concert with the Orchestra of the Age of Enlightenment on the science of sleep.

Among many other highlights, attendees were invited to ‘Knit-a-Neuron’ with Emma Palmer-Cooper, have a go at doing an endoscopy with Claire Pearson, and attend a dance performance of heart rhythms with researchers from the Radcliffe Department of Medicine. 

Read more (University of Oxford website)

#CuriosityCarnival Tweets

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.